Ara
Toplam kayıt 7, listelenen: 1-7
A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG)
(Imprimatur Publications, 2019)
Purpose: To compare the efficacy and adverse effect profiles of the first-line treatment of patients with KRAS wild type metastatic colorectal cancer (CRC) in Turkey who were treated based on regimens including bevacizumab, ...
The efficacy and safety analysis of the treatments of everolimus and exemestane combination in 101 metastatic breast cancer patients: Real-life experience from Turkey
(Amer Assoc Cancer Research, 2019)
[No abstract available]
Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer
(Sage Publications Ltd, 2019)
Objective This study aimed to evaluate the efficacy and safety profile of capecitabine and oxaliplatin (CAPOX) and 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimens as adjuvant treatment in patients with stage ...
Whıch Hematologıc Parameters Predıct Survıval in Patıents Wıth Small Cell Lung Cancer?
(2019)
Introduction : Small cell lung cancer(SCLC) is the most aggressive form of lung cancer. Recent studies showed that inflammation plays an important role in carcinogenesis. In this study, we investigated the survival impact ...
Clinical Significance of Serum 25-Hydroxyvitamin D Levels in Non-Small Cell Lung Cancer
(2019)
Objectives: Lung cancer is the most common cause of cancer-related deaths worldwide. The use of tobacco and tobacco products is among the leading risk factors with proven association with lung cancer, although various ...
Evaluation of oxaliplatin-induced pulmonary toxicity in rats
(Termedia Publishing House Ltd, 2019)
Introduction: The mechanism of oxaliplatin (OXA) induced pulmonary toxi-city is not fully understood. Aim of the study: The present study was designed to investigate the pulmonary toxicity of OXA that has been reported in ...
Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey
(Churchill Livingstone, 2019)
Objectives: This study aims to evaluate the frequency of use of CAM therapies among cancer patients, the types of CAM therapies they used, the demographic and clinical factors affecting their tendency to use CAM therapies, ...